Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longjin Tonglin Capsule for chronic prostatitis with semen abnormalities
ChiCTR2300068600Phase 4Recruiting
- Sponsor
- Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Tonglin Capsule in chronic prostatitis (CP) and male infertility, sponsored by Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. Primary endpoints: NIH Chronic Prostatitis Symptom Index (NIH-CPSI) score, Prostatic fluid parameters and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
Tonglin Capsule
03
Conditions
chronic prostatitis (CP)male infertility
Beyond the preview
Go deeper on ChiCTR2300068600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068600.